gentamicin has been researched along with meropenem in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.14) | 18.7374 |
1990's | 11 (12.50) | 18.2507 |
2000's | 15 (17.05) | 29.6817 |
2010's | 37 (42.05) | 24.3611 |
2020's | 24 (27.27) | 2.80 |
Authors | Studies |
---|---|
Andrews, JM; Ashby, JP; Wise, R | 1 |
Clark, RB; Joyce, SE | 1 |
Coulthard, M; Ehrett, S; Friedland, IR; Jafari, H; McCracken, GH; Olsen, K; Paris, M; Rinderknecht, S; Saxen, H | 1 |
Edwards, JR; Nairn, K; Shepherd, GL | 1 |
Iaconis, JP; Nadler, HL; Pitkin, DH; Sheikh, W | 1 |
Faro, S; Gall, S; Hemsell, DL; Martens, MG; McGregor, JA | 1 |
Tuohy, M; Washington, JA | 1 |
Aleksandrova, IA; Grudinina, SA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
Buiting, A; Hoepelman, IM; Jaspers, CA; Kieft, H; Olink, AG; Ruys, GJ; Speelberg, B; van Marwijk Kooij, M; Vermeulen, MC; Vincent, HH | 1 |
Babini, GS; Bates, J; Livermore, DM; Palepou, MF; Woodford, N | 1 |
Allerberger, F; Hasse, J; Miglioli, PA; Walderberg, I | 1 |
Dawis, MA; France, KA; Isenberg, HD; Jenkins, SG | 1 |
Jones, RN; Rhomberg, PR | 1 |
Aarestrup, FM; Aldrobi, J; Beyer, J; Bodeis, SM; Brosnikoff, C; Brown, S; Critchley, IA; Fedorka-Cray, P; Flamm, R; Graff, S; Hanson, RA; Johnson, MM; Jones, RN; McDermott, PF; Mirrett, S; Piddock, LJ; Reller, B; Rennie, R; Ricci, V; Schooley, S; Shortridge, D; Stein, G; Thornsberry, C; Traczewski, M; Turnbull, L; Walker, RD; Wallace, M | 1 |
Doroszkiewicz, W; Dorotkiewicz-Jach, A; Drulis-Kawa, Z; Gubernator, J; Kozubek, A | 1 |
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
Falagas, ME; Siempos, II; Tsakoumis, I | 1 |
Bokaei, S; Etemadi, G; Feizabadi, MM; Rahmati, M; Shabanpoor, S; Yadegarinia, D | 1 |
Bauer, F; Cauda, R; Freybergh, FP; Huttova, M; Kalavsky, E; Kisac, P; Miklosko, J; Ondrusova, A; Rudinsky, B | 1 |
Bedenić, B; Drenjancević, D; Sakić-Zdravcević, K; Vranes, J | 1 |
Bilewska, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J | 1 |
Dervisoglu, E; Yegenaga, I; Yumuk, Z | 1 |
Abubaker, J; Khan, SG; Khursheed, M; Noman, F; Noor, SA | 1 |
Jayasinghe, PN; Nanayakkara, GM; Pethiyagoda, P; Premachandra, U | 1 |
Adukauskiene, D; Dambrauskiene, A; Jeroch, J; Vitkauskiene, A | 1 |
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L | 1 |
Appelbaum, PC; Ednie, LM; Lin, G; Pankuch, GA | 1 |
Coban, AY; Durupinar, B; Guney, AK; Tanriverdi Cayci, Y | 1 |
Boukovalas, S; Chryssouli, Z; Galani, I; Giamarellou, H; Gourgoulis, MG; Kanellakopoulou, K; Panagea, T; Souli, M | 1 |
Brown, D; Drusano, GL; Heine, HS; Kulawy, R; Liu, W; Louie, A; Vanscoy, B | 1 |
Enblad, P; Sjölin, J; Tängdén, T; Ullberg, M | 1 |
An, HM; Cha, MK; Ha, NJ; Kim, JR; Kim, MJ; Lee, DK; Lee, KO; Lee, SW | 1 |
Dilmen, U; Erdeve, O; Kılıç, S; Kızılelma, A; Oğuz, SS; Saygan, S; Zergeroğlu, S | 1 |
Cho, B; Im, SA; Park, GS; Yun, DY | 1 |
Gon, Y; Hara, H; Murase, S; Nakazawa, K; Otsubo, R; Park, K | 1 |
Ball, TB; Bowler, LL; Saward, LL; Zhanel, GG | 1 |
Acicbe, O; Coban, AY; Deveci, A; Durupinar, B; Tanyel, E; Yaman, G | 1 |
Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A | 1 |
Labrou, M; Manousaka, S; Michail, G; Pitiriga, V; Pournaras, S; Sakellaridis, N; Tsakris, A | 1 |
Chen, O; Kwan, C; Moskovits, M; Radionova, S; Sadiq, A | 1 |
Bueters, RR; Klaasen, A; Kusters, LJ; Schreuder, MF; van den Heuvel, LP | 1 |
Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
Albright, AL; Ferson, S; Ochieng', N; Okechi, H | 1 |
Grossman, TH; Kerstein, KO; O'Brien, W; Sutcliffe, JA | 1 |
Brair, A; Gray, J; Toozs-Hobson, P | 1 |
Bahl, MI; Frost, M; Hansen, T; Holst, JJ; Jensen, US; Knop, FK; Licht, TR; Mikkelsen, KH; Pedersen, O; Rehfeld, JF; Rosenberg, J; Vilsbøll, T | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC | 1 |
Bogdanová, K; Froning, JP; Havrdová, M; Hradilová, Š; Kilianová, M; Kolář, M; Kvítek, L; Panáček, A; Prucek, R; Röderová, M; Smékalová, M; Večeřová, R; Zbořil, R | 1 |
Chen, TL; Chuang, MF; Huang, WC; Kuo, SC; Lauderdale, TL; Lee, Y; Tseng, KC; Yang, YS | 1 |
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ | 1 |
Arena, A; Coppo, E; Del Bono, V; Fucile, C; Giacobbe, DR; Gratarola, A; Marchese, A; Marini, V; Martelli, A; Mattioli, F; Molin, A; Parisini, A; Pelosi, P; Viscoli, C | 1 |
Bandara, KA; Chandrasiri, NS; Hapuarachchi, CT; Kailainathan, A; Wijekoon, PW | 1 |
Dinic, M; Kocic, B; Mitic, R; Mladenovic-Antic, S; Petrovic, J; Randjelovic, G; Velickovic-Radovanovic, R | 1 |
Gholami, S; Sohrabi, N; Tabatabaei, M | 1 |
Ambretti, S; Campoli, C; Gaibani, P; Giannella, M; Landini, MP; Lewis, RE; Re, MC; Viale, P; Volpe, SL | 1 |
Heather, CS; Maley, M | 1 |
Bail, L; da Silva Nogueira, K; Dalmolin, TV; Ito, CAS; Martins, AF; Martins, AS; Rocha, JLL; Serio, AW; Tuon, FF | 1 |
English, AM; Khakimova, M; Martins, D; McKay, G; Nguyen, D; Sampathkumar, G | 1 |
Nielsen, SY; Nørskov-Lauritsen, N | 1 |
Amarasena, HLP; Jayamanne, SF; Ranawaka, UK; Silva, FHDS; Tilakaratna, PMYI | 1 |
Martin, A; Miletin, J; O'Sullivan, A; Raba, AA; Semberova, J | 1 |
Galani, I; Giamarellou, H; Karaiskos, I; Karantani, I; Papadimitriou, E; Papoutsaki, V | 1 |
De Ponti, F; Gatti, M; Raschi, E | 1 |
Albayrak, A; Fakioğlu, DM; Şenol, E | 1 |
Pliska, NN | 1 |
Alves, LC; Brayner, FA; Firmo, EF; Lopes, ACS; Oliveira Júnior, JB; Scavuzzi, AML; Veras, DL | 1 |
Anderson, EM; Barnett Foster, DE; Khursigara, CM; Park, AJ; Puño-Sarmiento, J | 1 |
Bernal Andres, B; Gonzalez Moreno, M; Tkhilaishvili, T; Trampuz, A; Wang, L | 1 |
Arend, LNVS; Chaiben, V; Dantas, LR; de Andrade, AP; Ribeiro, VST; Suss, PH; Telles, JP; Tuon, FF; Yamada, CH | 1 |
Daneman, N; Elligsen, M; Katz, K; Lam, PW; Lo, J; MacFadden, D; Teitelbaum, D; Vermeiren, C | 1 |
Aiesh, BM; Alsayed, RB; Amer, R; Rabayah, R; Sabateen, A; Salameh, H; Taha, AA; Zyoud, SH | 1 |
Chung, KK; DeLuca, JP; Kress, AT; Reed, T; Selig, DJ; Stewart, IJ | 1 |
Ardebili, A; Bagheri, H; Goharrizi, MASB; Hjimohammadi, A; Izanloo, A; Jamali, A; Shahri, FN | 1 |
Bakkaloglu, Z; Demirbas, Z; Dizbay, M; Ozger, HS; Suzuk-Yildiz, S | 1 |
Fuglebjerg, NJU; Harboe, ZB; Højgaard, SMM; Knudsen, JD; Nielsen, SD; Rezahosseini, O; Skov, M | 1 |
Fujita, S; Hatasaki, K; Igarashi, N; Kaneko, S; Kuroda, M; Ueno, K; Wada, T | 1 |
Assenga, EN; Godfrey, E; Majaliwa, E | 1 |
Adu-Asiamah, CK; Aglomasa, BC; Amewu, EKA; Amponsah, IK; Asiedu, SO; Boahen, KG; Boakye, YD; Boamah, VE; Kini, P; Kwarteng, A; Wireko, S | 1 |
Chen, J; Liu, W; Zhao, F | 1 |
Ghorbani, G; Rahimi, E; Shakerian, A | 1 |
Adeli-Sardou, M; Forootanfar, H; Ghafari-Shahrbabaki, SS; Jabari-Morouei, F; Mehrabani, M; Riahi-Madvar, S; Shakibaie, M | 1 |
Bowness, R; Falconer, K; Gillespie, SH; Hammond, RJH; Powell, T | 1 |
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
Hiddema, JS | 1 |
Badawy, MSEM; Elkhatib, WF; Shebl, RI | 1 |
Bulagonda, EP; Khamari, B; Nandi, D; Singh, S; Umapathy, S; Verma, T | 1 |
1 review(s) available for gentamicin and meropenem
Article | Year |
---|---|
[Case of an elderly patient with community acquired bacterial meningitis due to extended spectrum β lactamase producing Escherichia coli].
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infusions, Intravenous; Meningitis, Bacterial; Meropenem; Thienamycins; Treatment Outcome | 2012 |
3 trial(s) available for gentamicin and meropenem
Article | Year |
---|---|
A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clindamycin; Diarrhea; Drug Therapy, Combination; Eosinophilia; Female; Genital Diseases, Female; Gentamicins; Hospitalization; Humans; Meropenem; Microbial Sensitivity Tests; Pelvic Inflammatory Disease; Pregnancy; Pregnancy Complications, Infectious; Thienamycins; Thrombocytopenia | 1997 |
Meropenem versus cefuroxime plus gentamicin for treatment of serious infections in elderly patients.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Cefuroxime; Double-Blind Method; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Meropenem; Thienamycins; Treatment Outcome | 1998 |
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Load; Blood Glucose; Diarrhea; Fasting; Feces; Gastrointestinal Hormones; Gastrointestinal Microbiome; Gentamicins; Glucose; Humans; Insulin; Male; Meropenem; Postprandial Period; Thienamycins; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
84 other study(ies) available for gentamicin and meropenem
Article | Year |
---|---|
The antibacterial activity of meropenem in combination with gentamicin or vancomycin.
Topics: Carbapenems; Colony Count, Microbial; Culture Media; Drug Therapy, Combination; Gentamicins; Kinetics; Meropenem; Methicillin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins; Vancomycin | 1989 |
Activity of meropenem and other antimicrobial agents against uncommon gram-negative organisms.
Topics: Anti-Bacterial Agents; Ceftriaxone; Gentamicins; Gram-Negative Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Thienamycins | 1993 |
Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Chloramphenicol; Endotoxins; Escherichia coli Infections; Gentamicins; Inflammation; Male; Meningitis, Bacterial; Meropenem; Rabbits; Thienamycins | 1993 |
Efficacy of meropenem in experimental meningitis.
Topics: Ampicillin; Animals; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Gentamicins; Guinea Pigs; Haemophilus Infections; Haemophilus influenzae; Listeriosis; Meningitis, Bacterial; Meropenem; Neisseria meningitidis; Penicillin G; Pneumococcal Infections; Thienamycins | 1995 |
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
[Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1998 |
Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Thienamycins; Time Factors | 1998 |
Carbapenemase-producing Pseudomonas aeruginosa in UK.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Gentamicins; Humans; Imipenem; Meropenem; Metalloproteins; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; United Kingdom | 1998 |
Antibacterial activity of human pleural fluid: alone and in combination with antibiotics.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Escherichia coli; Gentamicins; Humans; Immunity, Innate; Meropenem; Microbial Sensitivity Tests; Middle Aged; Paraneoplastic Syndromes; Pleural Effusion, Malignant; Proteus; Staphylococcus aureus; Thienamycins | 1998 |
In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefepime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Gatifloxacin; Gentamicins; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Thienamycins | 2003 |
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America.
Topics: Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Meropenem; Microbial Sensitivity Tests; North America; Sensitivity and Specificity; Thienamycins; Tobramycin | 2003 |
Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem.
Topics: Campylobacter; Ciprofloxacin; Doxycycline; Erythromycin; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Quality Control; Thienamycins | 2004 |
A comparison of the in vitro antimicrobial activity of liposomes containing meropenem and gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Gentamicins; Liposomes; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem.
Topics: Adolescent; Anti-Bacterial Agents; Appendectomy; Appendicitis; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Postoperative Complications; Sepsis; Thienamycins | 2006 |
Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran.
Topics: Anti-Infective Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Imipenem; Iran; Klebsiella pneumoniae; Male; Meropenem; Thienamycins | 2006 |
Pseudomonas aeruginosa causing nosocomial meningitis in neonates and children: overview of 15 cases within 10 years.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Chi-Square Distribution; Child, Preschool; Chloramphenicol; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Meropenem; Pseudomonas Infections; Retrospective Studies; Risk Factors; Survival Analysis; Thienamycins | 2007 |
In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Blood Bactericidal Activity; Ceftazidime; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 2007 |
[Antibmicrobial susceptibility of Serratia marcescens isolated from hospitalized patients in 2003 - 2005].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Poland; Serratia marcescens; Thienamycins | 2007 |
Citrobacter freundii peritonitis and tunnel infection in a patient on continuous ambulatory peritoneal dialysis.
Topics: Adult; Anti-Bacterial Agents; Catheterization; Citrobacter freundii; Device Removal; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Meropenem; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Thienamycins | 2008 |
"Moraxella lacunata" endocarditis treated with penicillin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Endocarditis, Bacterial; Gentamicins; Humans; Male; Meropenem; Metronidazole; Moraxellaceae Infections; Penicillins; Protein Synthesis Inhibitors; Thienamycins; Vancomycin | 2008 |
Chromobacterium violaceum infection in a provincial hospital in Sri Lanka.
Topics: Anti-Bacterial Agents; Bacteremia; Chromobacterium; Fatal Outcome; Gentamicins; Gram-Negative Bacterial Infections; Hospitals, Public; Humans; Infant; Male; Meropenem; Protein Synthesis Inhibitors; Sri Lanka; Thienamycins | 2008 |
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Thienamycins; Wound Infection | 2009 |
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins | 2009 |
Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Synergism; Gentamicins; Lipoglycopeptides; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rifampin; Thienamycins; Time Factors | 2010 |
Effect of 1-(1-Naphtylmethyl)-piperazine, an efflux pump inhibitor, on antimicrobial drug susceptibilities of clinical Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enzyme Inhibitors; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Piperazines; Thienamycins | 2011 |
In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development.
Topics: Anti-Infective Agents; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; Gentamicins; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2011 |
Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
Topics: Ampicillin; Anti-Bacterial Agents; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Streptomycin; Thienamycins; Yersinia pestis | 2011 |
Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cerebral Ventriculitis; Cerebrospinal Fluid; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intraventricular; Meningitis, Bacterial; Meropenem; Middle Aged; Retrospective Studies; Surgical Wound Infection; Sweden; Thienamycins; Treatment Outcome; Young Adult | 2011 |
Antimicrobial activity of commonly used antibiotics and DNA fingerprint analysis of Pseudomonas aeruginosa obtained from clinical isolates and unchlorinated drinking water in Korea, 2010.
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; DNA Fingerprinting; Drinking Water; Drug Resistance, Bacterial; Female; Genotype; Gentamicins; Humans; Korea; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Nucleic Acid Amplification Techniques; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2011 |
[A case of neonatal meningitis due to Listeria monocytogenes serotype 1/2b].
Topics: Ampicillin; Anti-Bacterial Agents; Cerebrospinal Fluid; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Listeria monocytogenes; Meningitis, Listeria; Meropenem; Microbial Sensitivity Tests; Serotyping; Thienamycins; Vancomycin | 2011 |
Necrotic intramuscular chloroma with infection: magnetic resonance imaging features.
Topics: Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Child; Contrast Media; Cytarabine; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Gentamicins; Humans; Image Enhancement; Klebsiella Infections; Klebsiella pneumoniae; Leg; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Meropenem; Muscle Neoplasms; Necrosis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sarcoma, Myeloid; Teicoplanin; Thienamycins; Treatment Outcome | 2011 |
Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biofilms; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gene Expression; Gentamicins; Meropenem; Microbial Sensitivity Tests; Plankton; Pseudomonas aeruginosa; Thienamycins; Time Factors | 2012 |
In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Cephalosporins; Colistin; Dose-Response Relationship, Drug; Drug Antagonism; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gentamicins; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline | 2012 |
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins | 2013 |
Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli; Female; Gentamicins; Klebsiella pneumoniae; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Thigh; Tigecycline | 2013 |
Echocardiography: a case of coronary sinus endocarditis.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Coronary Sinus; Diagnosis, Differential; Endocarditis; Female; Follow-Up Studies; Gentamicins; Humans; Hypertension; Kidney Failure, Chronic; Meropenem; Renal Dialysis; Thienamycins; Treatment Outcome; Ultrasonography; Young Adult | 2014 |
Antibiotics and renal branching morphogenesis: comparison of toxicities.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Dose-Response Relationship, Drug; Fibroblast Growth Factor 8; Gene Expression Regulation, Developmental; Gentamicins; Gestational Age; Glial Cell Line-Derived Neurotrophic Factor; Meropenem; Mice, Inbred ICR; Morphogenesis; Nephrons; Thienamycins; Tissue Culture Techniques; Ureter | 2014 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Hydrocephalus; Infant; Kenya; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Treatment Outcome; Ventriculoperitoneal Shunt | 2015 |
Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coli.
Topics: Anti-Bacterial Agents; Biofilms; Colistin; Colony Count, Microbial; Escherichia coli Infections; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Tetracyclines; Thienamycins; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Local audit: How tightly should we police antibiotic prescribing for urinary tract infection and how should we modify national policy?
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Clinical Audit; Drug Resistance, Bacterial; England; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gentamicins; Health Policy; Humans; Meropenem; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Thienamycins; Trimethoprim; Urinary Tract Infections | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin | 2015 |
Silver nanoparticles strongly enhance and restore bactericidal activity of inactive antibiotics against multiresistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Gene Expression; Gentamicins; Klebsiella pneumoniae; Meropenem; Metal Nanoparticles; Microbial Sensitivity Tests; Silver; Thienamycins | 2016 |
In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Cefepime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Taiwan; Thienamycins | 2016 |
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin | 2016 |
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Colistin; Critical Illness; Drug Synergism; Drug Therapy, Combination; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Thienamycins; Tigecycline | 2017 |
Guillaine-barre syndrome; a rare complication of melioidosis. a case report.
Topics: Abdominal Pain; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Ceftazidime; Drug Resistance, Bacterial; Female; Gentamicins; Guillain-Barre Syndrome; Humans; Injections, Intravenous; Liver Abscess; Melioidosis; Meropenem; Peripheral Nervous System Diseases; Polymerase Chain Reaction; Splenic Diseases; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Gentamicins; Hospitals; Humans; Imipenem; Meropenem; Pseudomonas aeruginosa; Serbia; Thienamycins | 2016 |
Comparison of biofilm formation and antibiotic resistance pattern of Pseudomonas aeruginosa in human and environmental isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Ceftazidime; DNA, Bacterial; Drug Resistance, Bacterial; Environmental Microbiology; Genes, Bacterial; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; RNA, Ribosomal, 16S; Sigma Factor; Soil Microbiology; Thienamycins; Water Microbiology | 2017 |
In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Ertapenem; Gentamicins; Humans; Imipenem; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Thienamycins; Tigecycline | 2017 |
Automated direct screening for resistance of Gram-negative blood cultures using the BD Kiestra WorkCell.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood Culture; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2018 |
Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenem-Resistant Enterobacteriaceae; Colistin; Drug Resistance, Multiple, Bacterial; Gentamicins; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Sisomicin; Thienamycins | 2018 |
Superoxide dismutase activity confers (p)ppGpp-mediated antibiotic tolerance to stationary-phase
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Gentamicins; Ligases; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Signal Transduction; Superoxide Dismutase; Thienamycins | 2018 |
Multispacer sequence typing of Coxiella burnetii DNA from removed prosthetic heart valve material discloses first human case of infective endocarditis caused by MST_18.
Topics: Abscess; Aged; Aortic Valve; Coxiella burnetii; Denmark; DNA, Bacterial; Doxycycline; Echinocandins; Endocarditis, Bacterial; Fatal Outcome; Gentamicins; Heart Valve Prosthesis; Humans; Male; Meropenem; Metronidazole; Multilocus Sequence Typing; Rifampin; RNA, Ribosomal, 16S; Vancomycin | 2019 |
Melioidosis with a subdural collection - a case report.
Topics: Adult; Anti-Bacterial Agents; Brain; Brain Diseases; Burkholderia pseudomallei; Diabetes Complications; Diabetes Mellitus, Type 2; Doxycycline; Gentamicins; Humans; Magnetic Resonance Imaging; Male; Melioidosis; Meropenem; Subdural Space; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Are antibiotics a risk factor for the development of necrotizing enterocolitis-case-control retrospective study.
Topics: Anti-Bacterial Agents; Case-Control Studies; Enterocolitis, Necrotizing; Female; Gentamicins; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Meropenem; Retrospective Studies; Risk Factors | 2019 |
Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gentamicins; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tigecycline | 2020 |
Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Child; Child, Preschool; Colistin; Disease Outbreaks; Drug Combinations; Female; Gentamicins; Humans; Infant; Infant, Newborn; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Pharmacovigilance; Tigecycline; United Kingdom; Young Adult | 2019 |
Meropenem, rifampicin and gentamicin combination therapy in a patient with complicated urinary tract infection caused by extreme drug-resistant
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gentamicins; Humans; Male; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Urinary Tract Infections | 2020 |
Pseudomonas Aeruginosa as the Main Causative Agent of Osteomyelitis and its Susceptibility to Antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Chronic Disease; Doripenem; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies | 2020 |
In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates co-harbouring aminoglycoside-modifying enzymes, bla
Topics: Amikacin; Aminoglycosides; beta-Lactamases; Gentamicins; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Polymyxin B | 2020 |
Potentiation of Antibiotics by a Novel Antimicrobial Peptide against Shiga Toxin Producing E. coli O157:H7.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Escherichia coli O157; Gentamicins; Humans; Kanamycin; Meropenem; Microbial Sensitivity Tests; Pore Forming Cytotoxic Proteins; Real-Time Polymerase Chain Reaction | 2020 |
Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Biofilms; Ceftriaxone; Ciprofloxacin; Combined Modality Therapy; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Fosfomycin; Gentamicins; Meropenem; Microbial Sensitivity Tests; Moths; Phage Therapy; Prosthesis-Related Infections | 2020 |
A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Biofilms; COVID-19; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Pandemics; Polymyxins; Sulbactam | 2022 |
Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Ertapenem; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Microbial spectrum and drug resistance profile in solid malignancies in a large tertiary hospital from Palestine.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Retrospective Studies; Staphylococcus; Tertiary Care Centers | 2022 |
Hemoperfusion with Seraph 100 Microbind Affinity Blood Filter Unlikely to Require Increased Antibiotic Dosing: A Simulations Study Using a Pharmacokinetic/Pharmacodynamic Approach.
Topics: Anti-Bacterial Agents; Critical Illness; Gentamicins; Hemoperfusion; Humans; Imipenem; Meropenem; Vancomycin | 2023 |
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Deoxyribonucleases; Drug Resistance, Bacterial; Genotype; Gentamicins; Humans; Imipenem; Iran; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pancreatic Elastase; Phospholipases; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors | 2022 |
In Vitro Activity of Plazomicin Against Carbapenem Resistant Klebsiella pneumoniae Strains.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Gentamicins; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 2022 |
Characteristics and Outcomes of Patients with Delftia acidovorans Infections: a Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Colistin; Delftia acidovorans; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia; Young Adult | 2022 |
One-year-old boy with refractory Listeria monocytogenes meningitis due to persistent hypercytokinemia.
Topics: Adrenal Cortex Hormones; Ampicillin; Anti-Bacterial Agents; Cytokine Release Syndrome; Cytokines; Dexamethasone; Gentamicins; Humans; Infant; Listeria monocytogenes; Male; Meningitis, Listeria; Meropenem; Neopterin; Paralysis | 2022 |
Aetiology, antimicrobial susceptibility and outcome of children with sepsis, admitted at Muhimbili National Hospital, Dar es Salaam.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Clindamycin; Coagulase; Cross-Sectional Studies; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Sepsis; Staphylococcus aureus; Tanzania | 2022 |
Multi-drug resistant bacteria isolates from lymphatic filariasis patients in the Ahanta West District, Ghana.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Ceftazidime; Chloramphenicol; Ciprofloxacin; Elephantiasis, Filarial; Erythromycin; Escherichia coli; Escherichia coli Infections; Gentamicins; Ghana; Humans; Infant; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines | 2022 |
Analysis of drug resistance genes of integrons in clinical isolates of Escherichia coli from elderly bloodstream infections.
Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefoxitin; Clavulanic Acid; Drug Resistance; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Integrons; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Sepsis; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Antibiotic resistance's Genotypic and Phenotypic Characteristics and the Frequency of Virulence Factors in
Topics: Anti-Bacterial Agents; Chloramphenicol; Drinking Water; Enrofloxacin; Erythromycin; Gentamicins; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Mineral Waters; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2022 |
Cytotoxicity and anti-biofilm activities of biogenic cadmium nanoparticles and cadmium nitrate: a preliminary study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cadmium; Gentamicins; Kanamycin; Meropenem; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanoparticles; Pseudomonas aeruginosa; Staphylococcus aureus; Streptomycin; Tetracyclines; Vancomycin | 2022 |
A simple label-free method reveals bacterial growth dynamics and antibiotic action in real-time.
Topics: Anti-Bacterial Agents; Cefoxitin; Gentamicins; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |
Periprosthetic joint infection:A South African perspective.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Cross-Sectional Studies; Gentamicins; Humans; Meropenem; Prosthesis-Related Infections; Reoperation; Retrospective Studies; South Africa; Vancomycin | 2023 |
Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime/colistin versus gentamicin/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm.
Topics: Anti-Bacterial Agents; Biofilms; Ceftazidime; Colistin; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2023 |
Antimicrobial Resistance Studies Using Raman Spectroscopy on Clinically Relevant Bacterial Strains.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Bacterial; Gentamicins; Lipids; Meropenem; Microbial Sensitivity Tests; Nitrofurantoin; Spectrum Analysis, Raman | 2023 |